B 组链球菌脓毒症风险的管理：健康足月新生儿。
Management of Group B streptococcal sepsis risk in well, term newborns.
机构信息
University College Hospital NHS Trust, London, UK.
出版信息
Acta Paediatr. 2012 Feb;101(2):128-31. doi: 10.1111/j.1651-2227.2011.02447.x. Epub 2011 Sep 23.
AIM
To investigate how clinically well, term newborns at risk of early-onset Group B streptococcal (EOGBS) disease are currently managed in the United Kingdom (UK).
METHODS
Review of guidelines of UK neonatal units.
RESULTS
One hundred and twenty-five guidelines covering 157 neonatal units were received (71% of UK units), three of which were excluded from the review. We found great variation in every aspect for the management of EOGBS disease risk including the following: definition of risk factors; management of at-risk newborns; choice of antibiotics.
CONCLUSION
Our findings highlight the need for national consensus guidelines and clinical trials into the management of risk babies at risk of EOGBS disease.
目的
调查目前英国（英国）如何对患有早发性 B 组链球菌（EOGBS）疾病风险的足月新生儿进行临床管理。
方法
审查英国新生儿单位的指南。
结果
共收到 125 条涵盖 157 个新生儿单位的指南（占英国单位的 71％），其中有 3 条被排除在审查范围之外。我们发现，在管理 EOGBS 疾病风险的各个方面都存在很大差异，包括以下内容：危险因素的定义；高危新生儿的管理；抗生素的选择。
结论
我们的研究结果表明，需要制定国家共识指南，并进行临床试验，以管理患有 EOGBS 疾病风险的高危婴儿。
Zotero 插件